Stock 002550 CHANGZHOU QIANHONG BIOPHARMA CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Changzhou Qianhong Biopharma CO.,LTD

Equities

002550

CNE100001070

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 29/05/2024 BST 		5-day change 1st Jan Change
5.7 CNY +0.53% Intraday chart for Changzhou Qianhong Biopharma CO.,LTD -2.23% -3.06%
04-25 Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Changzhou Qianhong Biopharma CO.,LTD Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024
CI
Changzhou Qianhong Biopharma CO.,LTD Proposes Final Cash Dividend for the Year 2023
CI
Tranche Update on Changzhou Qianhong Biopharma CO.,LTD's Equity Buyback Plan announced on January 3, 2024.
CI
Changzhou Qianhong Biopharma CO.,LTD's Equity Buyback announced on January 3, 2024 has closed with 25,000,000 shares, representing 1.95% for CNY 140.76 million.
CI
Changzhou Qianhong Biopharma CO.,LTD announces an Equity Buyback for CNY 170 million worth of its shares.
CI
Changzhou Qianhong Biopharma CO.,LTD authorizes a Buyback Plan.
CI
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Changzhou Qianhong Biopharma Co.,Ltd Announces Cash Dividend on A Shares for 2022, Payable on May 26, 2023
CI
Changzhou Qianhong Biopharma CO.,LTD Approves Cash Dividend for 2022
CI
Tranche Update on Changzhou Qianhong Biopharma CO.,LTD's Equity Buyback Plan announced on April 15, 2023.
CI
Changzhou Qianhong Biopharma CO.,LTD's Equity Buyback announced on April 15, 2023 has closed with 5,000,000 shares, representing 0.39% for CNY 30.09 million.
CI
Changzhou Qianhong Biopharma CO.,LTD Proposes Final Cash Dividend for 2022
CI
Changzhou Qianhong Biopharma CO.,LTD announces an Equity Buyback for CNY 34 million worth of its shares.
CI
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Changzhou Qianhong Biopharma Co.,Ltd authorizes a Buyback Plan.
CI
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Qianhong Bio Pharma to Invest $85 Million in New Drug Production Base
MT
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002550 Stock
  4. News Changzhou Qianhong Biopharma CO.,LTD
  5. Highlights